Javier
Marhuenda
ab,
Sonia
Medina
*a,
Pedro
Martínez-Hernández
cd,
Simón
Arina
d,
Pilar
Zafrilla
b,
Juana
Mulero
b,
Camille
Oger
e,
Jean-Marie
Galano
e,
Thierry
Durand
e,
Federico
Ferreres
a and
Angel
Gil-Izquierdo
*a
aResearch Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 164, 30100 Campus University Espinardo, Murcia, Spain. E-mail: smescudero@cebas.csic.es; angelgil@cebas.csic.es; Fax: +34 968396213; Tel: +34 968396200 ext. 6253 Tel: +34 968396200 ext. 6363
bDepartment of Food Technology and Nutrition, Catholic University of San Antonio, Murcia 30107, Spain
cLab of Clinical Analysis, University Hospital Virgen de la Arrixaca, Murcia, Spain
dBodegas Baigorri S.A.U., Ctra. Vitoria-Logroño Km. 53, 01307 Samaniego, Álava, Spain
eInstitut des Biomolécules Max Mousseron (IBMM), UMR 5247 - CNRS - University of Montpellier - ENSCM, Faculty of Pharmacy, Montpellier, France
First published on 25th November 2016
Adrenic acid (AdA) and docosahexaenoic acid (DHA) peroxidation produces F2-dihomo-IsoPs and neuroprostanes, which have been related to oxidative damage in the central nervous system. Besides polyphenols, melatonin (MEL) and hydroxytyrosol (OHTyr) could be partly responsible for the antioxidant benefits of red wine (excluding colon derivatives). In order to elucidate whether these compounds are responsible for the protective antioxidant effects of red wine, a double-blind, crossover, placebo-controlled in vivo study – involving the intake of red wines and their native musts by healthy volunteers – was performed. The urinary metabolites decreased after the administration of red wines, to a greater extent than after the intake of their corresponding musts or ethanol. Melatonin is the most effective compound that protects adrenic acid from oxidative attack, judged by the reduction in the formation of F2-dihomo-isoprostanes. Similarly, hydroxytyrosol, being the most effective bioactive compound in reducing the formation of F3-neuroprostanes n-6 DPA and F4-neuroprostanes, protected docosahexaenoic and eicosapentaenoic acids from oxidative attack.
The Mediterranean Diet (MD) has been shown to exert several benefits with regard to the maintenance of the redox balance in humans. Polyphenols have been thought to be mainly responsible for the antiradical effects of the foodstuffs included in the MD.6 Wine is a representative alcoholic component of the MD, considered responsible for the “French Paradox”.7 In fact, ethanol exhibits antioxidant capacity in vivo.7 Therefore, alcohol could be partially responsible for the effects of red wine. Moreover, red wine polyphenols have demonstrated an in vivo and in vitro antioxidant capacity.6,8 Nevertheless, despite these beneficial effects, polyphenols have very-low in vivo and in vitro bioavailability.1,9 Aside from the more-deeply-studied polyphenols, melatonin (MEL), hydroxytyrosol (OHTyr), and their metabolites arising from the metabolic activity of the colonic microflora (such as homovanillic alcohol and homovanillic acid), among other known and/or unknown compounds, could be partly responsible for the antioxidant benefits of red wine.10,11 In turn, MEL could be responsible for the health effects of the Mediterranean diet.12 Such bioactive compounds act as radical scavengers, regulating the oxidation status of organisms.10 Moreover, both compounds are able to go through physiological barriers, in particular the blood–brain barrier (BBB). Therefore, their neuroprotective capacity has been related previously.13
The current research aims to elucidate, for the first time, the neuroprotection against oxidative stress provided by red wine, measured by urinary neuroprostanes and dihomo-isoprostanes.
Urine samples were obtained equally in all the stages of the study (graphically represented in Fig. 1). At 0 hours, the first urine in the morning was obtained both before and after the crossover. Additionally, samples were collected from 0 to 48 hours in order to establish the in vivo effects of the intake of the different beverages. Importantly, the data obtained are expressed in μg per 24 h in order to facilitate the comparison with the previously reported data.
For the enzymatic hydrolysis, to remove the glucuronide and sulfate conjugates, 1 mL of urine was added to 250 μL of 0.1 M acetate buffer (pH 4.9) and 55 μL of β-glucuronidase from Helix pomatia. The mixture was incubated at 37 °C in a thermal block for two hours. After this step, protein precipitation was carried out with 500 μL of methanol/chlorhydric acid (200 μM). Then, the samples were centrifuged at 10000g for 5 min.16
One milliliter of the supernatant was subjected to solid phase extraction (SPE) using a Strata X-AW cartridge (100 mg/3 mL), according to Medina et al. (2015).16 Briefly, samples that had been diluted in 2 mL of methanol and 1.25 mL of BIS-TRIS buffer were passed through the previously-conditioned and equilibrated cartridges. The analytes were eluted with 1 mL of methanol and dried under vacuum using a SpeedVac concentrator (Savant SPD121P, Thermo Scientific, MA, USA). The dry extracts were reconstituted with the A:
B (90
:
10, v
:
v) mobile phases and filtered through a 0.45 μm filter (Millipore, MA, USA). The samples were injected and analyzed by using UHPLC-QqQ-MS/MS.
The urinary NeuroPs and F2-dihomo-IsoPs were extracted from the 24 h urines.16 Chromatographic separation was carried out on an ACQUITY BEH C18 column (2.1 × 50 mm, 1.7 μm pore size) (Waters, MA, USA). The column temperatures were 6 °C (left) and 6 °C (right). Sample analysis was carried out as reported by Medina et al. (2015). The multiple reaction monitoring (MRM) mode was employed using the negative electrospray ionization (ESI) mode. The mobile phases A (water) and B (methanol) contained 0.01% acetic acid (v:
v). The flow rate was 0.2 mL min−1, using a linear gradient scheme (t; %B): (0.0; 60.00), (7.00; 70.00), (7.01; 90.00), (10.00; 90.00), and (10.01; 60.00).
The injection volume was 20 μL in UHPLC-QqQ-MS/MS. The operating conditions for the MS were as follows: gas flow 8 L min−1, nebulizer 30 psi, capillary voltage 4000 V, nozzle voltage 1000 V, gas temperature 325 °C, sheath gas temperature 350 °C, and jetstream gas flow 12 L min−1. The time for a single analysis was 10.01 min. The MS parameters fragmentor (ion optics) and collision energy were optimized for each compound to generate the most abundant product ions. Data acquisition and processing were performed using MassHunter software version B.04.00 (Agilent Technologies, Walbronn, Germany). The urinary amounts of the NeuroPs/F2-dihomo-IsoPs were calculated from the area ratio of the ion peaks of the compounds to those of the corresponding standards (expressed as ng of analytes excreted over 24 h).
For the determination of OHTyr and its metabolites, a UHPLC coupled to a 6460 QqQ-MS/MS (Agilent Technologies, Waldbronn, Germany) was used, following the method designed by Domínguez-Perles et al. (2015).19
For the analysis of MEL and serotonin, the extraction procedure for the wines and musts was as previously described.20 The separation and determination of MEL and serotonin were performed using a UHPLC coupled to a 6460 QqQ-MS/MS (Agilent Technologies, Waldbronn, Germany) and a Waters Acquity UHPLC BEH C18 1.7 μm 2.1 × 50 mm column.
To determine the individual involvement of the different bioactive compounds and the total phenolic content of lipid peroxidation products, simple regression analysis (R2) was performed. This statistical method allows one to know about the individual relationship of each of the bioactive compounds and TPC with the plasmatic concentration of lipid peroxidation products. However, since both wines and musts are matrices composed of various compounds of interest, it is essential to study all relationships simultaneously. Therefore, the results obtained after determining the simple regression were contrasted with multiple regression analysis (stepwise mode), in order to establish a real-based relationship. These analyses were performed with SPSS version 21 software (SPSS Inc., Chicago, IL, USA).
Melatonin (ng mL−1) | Ethanol (g per dose)a | Hydroxytyrosol metabolites (μg mL−1) | |||
---|---|---|---|---|---|
Homovanillic acid | Homovanillic alcohol | Hydroxytyrosol | |||
WR: white rum; MCW/MCM: carbonic maceration wine/must; AW/AM: aged wine/must; HEW/HEM: high expression wine/must.a It is considered as the total dose ingested over 48 hours: 74 mL of white rum and 200 mL of wine and must. | |||||
WR | — | 4.14 | — | — | — |
CMW | 161.83 ± 7.14a | 4.14 | 83.46 ± 13.59c | 189.23 ± 8.71a | 16.13 ± 2.98b |
CMM | 0.41 ± 0.039d | — | 130.76 ± 1.32a | 14.63 ± 0.17c | 0.53 ± 0.05c |
AW | 26.31 ± 1.35b | 4.14 | 74.38 ± 0.68c | 65.51 ± 1.31b | 29.65 ± 0.46a |
AM | 1.24 ± 0.13c,d | — | 112.41 ± 3.12a,b | 16.22 ± 1.02c | 0.96 ± 0.09c |
HEW | 19.63 ± 1.14b | 4.14 | 75.94 ± 7.29c | 51.56 ± 6.27b | 35.11 ± 2.51a |
HEM | 0.03 ± 0.004d | — | 101.04 ± 2.21a,b | 60.59 ± 1.31b | 0.54 ± 0.03c |
CMW | CMM | AW | AM | HEW | HEM | |
---|---|---|---|---|---|---|
WR: white rum; MCW/MCM: carbonic maceration wine/must; AW/AM: aged wine/must; HEW/HEM: high expression wine/must. Concentration of polyphenolic compounds is expressed in μg mL−1. | ||||||
Delphinidin-3-O-glucoside | 55.97 ± 2.18a | 12.11 ± 0.56c,d | 39.81 ± 0.48b | 12.96 ± 1.10c,d | 11.36 ± 0.47d | 14.63 ± 1.14c |
Cyanidin-3-O-glucoside | 2.45 ± 0.05b,c | 4.03 ± 0.17b | 3.44 ± 0.09b,c | 3.69 ± 0.08b | 0.60 ± 0.04c | 7.29 ± 0.88a |
Petunidin-3-O-glucoside | 54.73 ± 1.26a | 9.13 ± 0.59d | 30.21 ± 0.27b | 9.12 ± 0.98d | 8.17 ± 0.20d | 13.85 ± 0.95c |
Peonidin-3-O-glucoside | 11.77 ± 1.04b | 7.36 ± 1.52c | 10.96 ± 0.35b | 7.38 ± 0.74c | 3.37 ± 0.04d | 14.66 ± 1.39a |
Malvidin-3-O-glucoside | 236.87 ± 10.00a | 35.80 ± 2.30d | 90.10 ± 5.09b | 38.53 ± 20.00d | 35.19 ± 0.61c | 74.16 ± 3.29d |
Total anthocyanins | 361.79 ± 11.27a | 68.43 ± 3.71d | 174.53 ± 5.98b | 71.68 ± 3.25d | 58.68 ± 0.74c | 124.59 ± 4.56d |
Caftaric acid | 45.09 ± 4.52b,c | 0.59 ± 0.02d | 48.81 ± 0.03a,b | 0.31 ± 0.02d | 55.70 ± 4.73a | 2.35 ± 0.12d |
p-Coumaric acid | 1.30 ± 0.07c | ND | 10.59 ± 0.73b | ND | 14.42 ± 1.04a | ND |
Fertaric acid | 0.76 ± 0.04c | ND | 2.40 ± 0.08b | ND | 5.20 ± 0.30a | ND |
Coutaric acid | 40.82 ± 1.75a | 0.39 ± 0.06d | 13.69 ± 0.32c | 0.28 ± 0.02d | 20.54 ± 0.71b | 1.13 ± 0.10d |
Total hydroxycinnamic derivatives | 87.96 ± 6.39a | 0.98 ± 0.08c | 75.50 ± 1.15b | 0.59 ± 0.04c | 95.85 ± 6.77a | 3.48 ± 0.22c |
Myricetin-3-O-glucoside | 3.96 ± 0.06a | 1.06 ± 0.04c | 4.21 ± 0.23a | 1.00 ± 0.04c | 2.84 ± 0.26b | 1.22 ± 0.05c |
Quercetin-3-O-glucoside | 2.33 ± 0.21c | 0.63 ± 0.10d | 3.36 ± 0.12b | 0.60 ± 0.09d | 6.88 ± 0.25a | 0.73 ± 0.12d |
Quercetin-3-O-rutinoside | 33.37 ± 1.88b | 2.15 ± 0.14d | 24.93 ± 3.32c | 2.03 ± 0.14d | 49.77 ± 5.24a | 2.49 ± 0.17d |
Kaempferol-3-O-glucoside | 10.19 ± 1.27b | 2.54 ± 0.13d | 6.49 ± 0.34c | 2.39 ± 0.12d | 18.82 ± 1.28a | 2.93 ± 0.15d |
Myricetine | 5.08 ± 0.16a | 1.83 ± 0.17d | 2.30 ± 0.14c | 1.73 ± 0.16d | 3.71 ± 0.18b | 2.12 ± 0.19c,d |
Quercetine | 3.23 ± 0.13b | 1.79 ± 0.24c,d | 1.25 ± 0.03d | 1.69 ± 0.23c,d | 4.82 ± 0.16a | 2.06 ± 0.28c |
Total flavonols | 58.15 ± 1.31b | 10.01 ± 0.32c | 42.54 ± 4.18b | 9.43 ± 0.30c | 86.84 ± 4.22a | 11.55 ± 0.36c |
Piceatanol | 0.26 ± 0.02b | 0.08 ± 0.01c | 0.20 ± 0.01b | 0.08 ± 0.01c | 0.57 ± 0.04a | 0.27 ± 0.03b |
trans-Resveratrol | 4.85 ± 1.03a | 0.84 ± 0.06d | 2.10 ± 0.15c | 0.79 ± 0.08d | 3.37 ± 0.25b | 0.82 ± 0.06d |
Total stilbenes | 5.12 ± 1.05a | 0.92 ± 0.07c | 2.30 ± 0.16b | 0.87 ± 0.09c | 3.94 ± 0.29a | 1.09 ± 0.09b,c |
Total phenolic compounds (TPC) | 513.02 ± 20.02a | 80.34 ± 4.18c.d | 294.87 ± 11.47b | 82.57 ± 3.68c.d | 245.31 ± 12.02b | 140.71 ± 5.23c |
Regarding MEL, the musts contained similar and very low amounts of this compound, compared to the wines. The MEL concentration of the carbonic maceration must (CMM) was 0.41 ± 0.03 ng mL−1, aged must (AM) had 1.24 ± 0.13 ng mL−1, and high expression must (HEM) had 0.03 ± 0.004 ng mL−1. The MEL concentration found in carbonic maceration wine (CMW) (161.83 ± 7.14 ng mL−1) was higher than the other two wines (p < 0.01): the aged wine (AW) (26.31 ± 1.35 ng mL−1) and the high expression wine (HEW) (19.63 ± 1.14 ng mL−1) had similar concentrations (p > 0.05).
Red wine is one of the major dietary sources of OHTyr. The analysis of OHTyr and its metabolites yielded two metabolites related to the gut microflora, homovanillic acid (HV-Acid) and homovanillic alcohol (HV-Alc) (Table 1). The musts contained high amounts of HV-Acid, but lower contents of HV-Alc and a very low amount of OHTyr. HV-Alc followed a trend opposite to that of HV-Acid, its concentration increasing after winemaking for CMW and AW, but not for HEW (Table 1). The most important difference between the wines and musts was due to the increase in OHTyr after vinification (p < 0.05). As a result, HEW showed the highest OHTyr concentration of all the beverages (35.11 ± 2.51 μg mL−1), followed by AW (29.65 ± 0.46 μg mL−1) and CMW (16.13 ± 2.98 μg mL−1) (Table 1).
The concentrations found for every phenolic compound from wines and musts are shown in Table 2. Anthocyanins were the major phenolic compounds found in wines and musts. Among all the five anthocyanin glucosides, malvidin-3-O-glucoside was the major anthocyanin both in wines and musts (p < 0.05). Moreover, delphinidin-3-O-glucoside and petunidin-3-O-glucoside were also prominent from the rest of the anthocyanins. The individual content of hydroxycinnamic acid derivatives was divided into two groups. Caftaric acid and coutaric acid were the major compounds, mainly found in wines. On the contrary, p-coumaric acid and fertaric acid were minor compounds in wine, being undetectable in must. The individual analysis of the different flavonols identified revealed quercetin-3-O-rutinoside and kaempferol-3-O-glucoside as major flavonols. Finally, trans-resveratrol was the main stilbene, both in wines and musts.
Control | WR | CMW | CMM | AW | AM | HEW | HEM | ||
---|---|---|---|---|---|---|---|---|---|
Means are expressed in μg per 24 h. WR: white rum; MCW/MCM: carbonic maceration wine/must; AW/AM: aged wine/must; HEW/HEM: high expression wine/must. | |||||||||
NeuroPs | 4(R)-F4t | 2.40 ± 0.19 | 1.95 ± 0.22 | 1.27 ± 0.2 | 1.92 ± 0.20 | 1.27 ± 0.43 | 1.66 ± 0.36 | 1.02 ± 0.17 | 1.20 ± 0.20 |
4-epi-4-F3t | 0.67 ± 0.13 | 0.51 ± 0.11 | 0.41 ± 0.07 | 0.52 ± 0.19 | 0.48 ± 0.13 | 0.62 ± 0.21 | 0.37 ± 0.09 | 0.46 ± 0.08 | |
4-F3t | 0.26 ± 0.06 | 0.21 ± 0.05 | 0.18 ± 0.04 | 0.18 ± 0.04 | 0.19 ± 0.07 | 0.20 ± 0.07 | 0.19 ± 0.04 | 0.19 ± 0.06 | |
10-epi-10-F4t | 0.95 ± 0.24 | 1.12 ± 0.25 | 0.89 ± 0.18 | 0.73 ± 0.16 | 0.64 ± 0.28 | 0.86 ± 0.19 | 0.60 ± 0.17 | 0.56 ± 0.21 | |
10-F4t | 0.51 ± 0.11 | 0.85 ± 0.32 | 0.42 ± 0.09 | 0.36 ± 0.10 | 0.36 ± 0.20 | 0.39 ± 0.17 | 0.41 ± 0.17 | 0.37 ± 0.24 | |
F2-dihomo-IsoPs | 17-epi-17-F2t | 0.08 ± 0.02 | 0.05 ± 0.01 | 0.04 ± 0.02 | 0.04 ± 0.01 | 0.03 ± 0.01 | 0.05 ± 0.02 | 0.04 ± 0.04 | 0.04 ± 0.02 |
17-F2t | 0.70 ± 0.10 | 0.39 ± 0.09 | 0.31 ± 0.13 | 0.44 ± 0.09 | 0.25 ± 0.10 | 0.46 ± 0.08 | 0.28 ± 0.12 | 0.25 ± 0.09 | |
ent-7(R)-7-F2t | 3.15 ± 0.31 | 2.53 ± 0.33 | 1.30 ± 0.33 | 1.85 ± 0.35 | 1.66 ± 0.21 | 1.99 ± 0.18 | 1.41 ± 0.26 | 2.03 ± 0.43 | |
ent-7-epi-7-F2t | 2.21 ± 0.35 | 1.98 ± 0.39 | 0.89 ± 0.17 | 1.64 ± 0.22 | 1.03 ± 0.13 | 1.79 ± 0.32 | 1.27 ± 0.14 | 1.36 ± 0.22 |
The total amount of urinary NeuroPs found after the treatments varied widely (Fig. 2). The musts CMM and AM produced decreases (p < 0.05) in the urinary excretion of total NeuroPs, compared to the baseline concentration (4.78 ± 0.72 μg per 24 h), while the intake of HEM exerted a particularly-marked protective effect (p < 0.01) against the generation of these compounds (total NeuroP concentration: 2.81 ± 0.85 μg per 24 h). Regardless of the type, after the red wine intake the trend regarding the total NeuroP concentration was similar to that found after the ingestion of the different musts. Therefore, the three types of wine exerted similar DHA protection (p > 0.05). Nevertheless, only after the HEW intake was significant (p < 0.01) diminution of the total NeuroP level detected; of the three wines, HEW provided the lowest urinary concentration (3.17 ± 0.59 μg per 24 h). Alcohol intake, represented by the treatment with white rum (WR), did not exert neuroprotection. In fact, urinary excretion of total NeuroPs after WR intake was similar (4.64 ± 0.95 μg per 24 h) to the baseline level. HEW and HEM intake, among CMM, also produced lower total NeuroP excretion (p < 0.05) than WR.
None of the three types of red wine exerted higher DHA protection against NeuroP production than their corresponding musts (p < 0.05). However, the high expression must and wine (HEM and HEW) were able to reduce the urinary excretion of total NeuroPs, indicating the influence of the cultivation and harvesting of the grapes and of the winemaking process on the final DHA protection capacity of the resultant must and, consequently, of the finished wine. The vinification process did not seem to influence the antiradical properties of the final red wine when measured as the total NeuroP concentration in urine, according to the only-slight differences between each must and its corresponding finished wine (p > 0.05).
Regarding the individual variation of F2-dihomo-IsoPs, the concentrations in urine differed widely after the intake of the different musts. The baseline levels of 17-epi-17-F2t and 17-F2t in the urine were low (0.08 ± 0.02 μg per 24 h and 0.70 ± 0.10 μg per 24 h, respectively). After their administration to the healthy volunteers, CMM gave rise to urinary concentrations of both compounds that were similar to the baseline values (p > 0.05) (0.04 ± 0.01 μg per 24 h and 0.44 ± 0.09 μg per 24 h, respectively), AM intake resulted in lower values (p < 0.05) for 17-epi-17-F2t (0.05 ± 0.02 μg per 24 h), and HEM intake produced a drop in the concentrations of 17-epi-17-F2t (0.04 ± 0.012 μg per 24 h) and 17-F2t (0.25 ± 0.09 μg per 24 h) (Table 3).
The highest baseline urinary concentrations were observed for ent-7(R)-7-F2t (3.15 ± 0.31 μg per 24 h) and ent-7-epi-7-F2t (2.21 ± 0.35 μg per 24 h). The musts caused similar decreases in the ent-7(R)-7-F2t and ent-7-epi-7-F2t levels (p > 0.05). In fact, the ingestion of the musts significantly (p < 0.05) diminished the concentration of ent-7(R)-7-F2t (1.85 ± 0.35 μg per 24 h, 1.99 ± 0.18 μg per 24 h, 2.03 ± 0.43 μg per 24 h for MCM, AM and HEM intake, respectively). The urinary concentration of ent-7-epi-7-F2t showed the same tendency, being lower after the intake of CMM (1.64 ± 0.22 μg per 24 h), AM (1.79 ± 0.32 μg per 24 h) and HEM (1.36 ± 0.22 μg per 24 h), compared to the baseline (Table 3). The wines also provoked decreases of the ent-7(R)-7-F2t and ent-7-epi-7-F2t levels (p < 0.05). Thus, the ent-7(R)-7-F2t excretion after CMW (1.30 ± 0.33 μg per 24 h), AW (1.66 ± 0.21 μg per 24 h), or HEW (1.41 ± 0.26 μg per 24 h) intake was markedly lower than the corresponding baseline value (p < 0.05). The urinary excretion of ent-7-epi-7-F2t was 0.89 ± 0.17 μg per 24 h, 1.03 ± 0.13 μg per 24 h and 1.27 ± 0.14 μg per 24 h as a consequence of the administration of CMW, AW, and HEW, respectively (Table 3).
The dietary intake of alcohol (WR) reduced the concentration of ent-7(R)-7-F2t (to 2.4 ± 0.6 μg per 24 h), compared with the baseline (p < 0.05). However, the urinary concentrations of the other F2-dihomo-IsoPs remained unchanged (p > 0.05) (Table 3).
The winemaking processes did not influence the urinary concentration of individual NeuroPs: the differences observed between the musts and their respective wines were not significant (p > 0.05). Conversely, differences did occur for two urinary F2-dihomo-IsoPs. The urinary concentration of ent-7(R)-7-F2t was significantly higher (p < 0.05) after CMM intake than after CMW intake and the urinary concentration of ent-7-epi-7-F2t after the intake of AM was higher than after the intake of AW, highlighting the importance of the vinification process and the new compounds formed which boosted these effects on these markers.
Despite the health effects of polyphenols on humans, the scientific literature shows a very low bioavailability.28–30 Therefore, despite the antioxidant capacity of the polyphenols and the importance of these compounds in the wine and grape matrices, their low absorption appears to be a limiting factor when considering the intake of polyphenols as key factor in the antioxidant effects of red wine. In our study, the intake of unique polyphenols (OHTyr and total polyphenols) – not including colon derivatives (only OHTyr microflora metabolites) – has been approached in order to determine their preventive effect on lipid peroxidation. However, anthocyanins, being the major polyphenol in wine and must, have been demonstrated to be directly absorbed in the intestine.31 Moreover, other newly reported bioactive compounds in wine and must called phytoprostanes have shown healthy benefits regarding oxidative injury prevention and anti-inflammatory capacity. In fact, they have been reported to have absorption in the intestine although colonic metabolites have not yet been reported.3,32 Therefore, this work is a preliminary study that may help to understand the role of certain wine compounds in the oxidation of DHA, EPA and AdA.
Red wine has shown in vivo neuroprotective effects, mainly attributed to its polyphenolic composition and its antioxidant properties.23,33 As mentioned above, MEL and OHTyr can act as local antioxidants due to their capacity to traverse physiological barriers.10,34 To elucidate if MEL or OHTyr could be, at least partly, responsible for the observed neuroprotective effects of red wine, a regression study was carried out.
The results of regression analysis performed for the urinary excretion of total NeuroPs and total F2-dihomo-IsoPs are given in Table 4. As can be appreciated, the simple regression study shows that the excretion of NeuroPs is individually mainly explained by OHTyr intake (responsible for 15.5% of the observed variation). Meanwhile, the intake of MEL, HV-Acid, HV-Alc and TPC was responsible for 13.5%, 0.3%, 7.2% and 4.4% of the observed variation in the urinary excretion of NeuroPs, respectively. Finally, multiple regression analysis following the same trend was performed after simple regression, which showed little statistical weight for all compounds present in musts and wines. Only 23.6% of the observed change in the excretion of NeuroPs can be explained by the statistical model containing all the bioactive compounds and TPC simultaneously. This same model showed that the intake of OHTyr explains 16.5% of the observed change in the NeuroP variation, taking into account all the compounds included in the beverages. Therefore, it is clear that the excretion of NeuroPs must be influenced by various factors that cannot be determined in the present study. However, the intake of the various compounds (especially OHTyr) may be partially responsible for the decrease in the excretion of urinary NeuroPs.
Total NeuroPs | Total F2-dihomo-IsoPs | |
---|---|---|
MEL: melatonin; OHTyr: hydroxytyrosol; HV-Acid: homovanillic acid; HV-Alc: homovanillic alcohol; TPC: total phenolic compounds. R2 Tot.: coefficient of regression which expresses the statistical significance of all the compounds studied with respect to each biomarker. R2 Select.: coefficient of determination of compounds selected by the statistical robustness model. All these values are treated as % of influence on the final concentration. | ||
Simple regression (R2) | ||
MEL | 0.135 | 0.439 |
OHTyr | 0.155 | 0.207 |
HV-Acid | 0.003 | 0.080 |
HV-Alc | 0.072 | 0.331 |
TPC | 0.044 | 0.327 |
Multiple regression | ||
R2 Tot. | 0.236 | 0.441 |
R2 Select. | 0.165 (OHTyr) | 0.439 (MEL) |
The simple regression in relation to the excretion of F2-dihomo-IsoPs showed a greater influence of the different compounds contained in the beverages than discussed above for the urinary excretion of NeuroPs. By conducting the study of simple regression, the urinary excretion of F2-dihomo-IsoPs is explained in 43.9% by the intake of MEL, in 20.7% by OHTyr, in 8% by HV-Acid, in 33.1% by HV-Alc and in 32.7% by TPC. Moreover, the study of multiple regression showed that the observed variation in the excretion of F2-dihomo-IsoPs is explained in 44.1% by the whole compounds studied simultaneously. Overall, the intake of MEL was the most significant describing the observed variation, explaining 43.9% of the observed decrease in the urinary excretion of F2-dihomo-IsoPs.
The scientific literature about neuroprostanes and F2-dihomo-isoprostanes is still limited to a few description and synthesis papers. The description of neuroprostanes and F2-dihomo-isoprostanes in human fluids is restricted to physiopathological conditions such as Rett syndrome, brain injury or Alzheimer disease among others.35–39 Some studies have reported the reduction of other lipid peroxidation biomarkers as isoprostanes.40 However, it is not relevant in the present study due to the general location in the human body. Other studies reported a notable reduction in lipid peroxidation related to the central nervous system in young adult triathletes, showing similar values to those reported in the present study. García-Flores et al. reported that one serving of fruit juice rich in polyphenols leads to minor urinary excretion of neuroprostanes and dihomo-isoprostanes.41 They related those changes observed to the content of polyphenols of the fruit beverages. Therefore, the comparison of the physiological levels of the biomarkers with previous scientific literature is still limited in the case of a healthy population.
Therefore, all the bioactive compounds taken into account in this research study including TPC seem to exert neuroprotection. On one hand, MEL appears to exert its neuroprotective effect by the oxidative protection of AdA, measured by the formation of F2-dihomo-IsoPs. Meanwhile, OHTyr has proved to be responsible for the protection of DHA against oxidative species, determined by the measurement of the total production of NeuroPs.
According to the above statistical analysis, the differences observed among the wine and must treatments could be related to their MEL contents. The CMW, in which the concentration of MEL was the highest (161.83 ± 7.1 ng mL−1), was the only wine that gave a significantly greater decrease in total urinary F2-dihomo-IsoPs compared to its preceding must, CMM (p = 0.015). Taking into account these results, the fact that MEL can act as an antioxidant and its ability to cross the BBB, it is evident that MEL in wine must be considered with neuro-protection capacity.10 In particular, the decrease in urinary F2-dihomo-IsoPs, compared to the baseline level, is representative of protection of the white brain matter against oxidative stress.5 The effects of wine on lipid peroxidation have been found to result in a decrease in the production of oxidized compounds.40,42 Nonetheless, to the best of our knowledge, no reports about MEL or OHTyr and NeuroPs or F2-dihomo-IsoPs have been published. Therefore, this is the first in vivo assay of the relationship between the intake of these bioactive molecules as part of wine and neuroprotection.
There are few reports on the urinary excretion of F4-NeuroPs and F2-dihomo-IsoPs. However, similar results in urine were obtained using UHPLC-QqQ-MS/MS,16 reporting 3.30 ± 1.17 μg mL−1 for NeuroPs and 6.12 ± 1.51 μg mL−1 for F2-dihomo-IsoPs as mean values in a healthy population. Meanwhile, in epileptic patients there was greater degradation of neuronal membranes and myelin, giving mean values of 5.51 ± 1.86 μg mL−1 for NeuroPs and 7.81 ± 1.87 μg mL−1 for F2-dihomo-IsoPs. The urinary excretion of F4-NeuroPs and F2-dihomo-IsoPs was also studied in healthy subjects after the intake of a citrus-based juice,14 showing slightly higher values than those reported in the present study.
Additionally, NeuroPs and F2-dihomo-IsoPs have been described in other biological fluids such as plasma and cerebrospinal fluid. Other authors35 described a plasmatic increase of F4-NeuroPs in patients with Rett syndrome, compared to healthy subjects. Similarly, Durand et al. (2013)5 and De Felice, Signorini, Durand, Oger, Guy, Bultel-Poncé et al. (2011)36 found higher plasmatic levels of F2-dihomo-IsoPs in Rett syndrome patients. Finally, the cerebrospinal fluid content of F4-NeuroPs and F2-dihomo-IsoPs has also been reported, showing an increment of both biomarkers in many diseases such as brain injury, Alzheimer's disease, or aneurysmal subarachnoid hemorrhage.37–39
As expected, the vinification processes enhanced the neuroprotective effect of the wines, with regard to total-F2-dihomo-IsoPs, in comparison with the musts.34 In general, unless not statistically significant (p > 0.05), red wine intake resulted in a greater decrease of 24 h total F2-dihomo-IsoP excretion than the must intake did.
Consequently, the intake of CMW containing high quantities of melatonin and hydroxytyrosol could develop an increased reduction of oxidative injury compared to aged wines (AW and HEW). However, only hydroxytyrosol metabolites have been approached in the present study. Therefore, further studies may help to understand the effect of other bioactive compounds such as polyphenol's colon derivatives and newly discovered phytoprostanes on reducing central nervous system lipid peroxidation.
This journal is © The Royal Society of Chemistry 2017 |